Washington Regional Performs State's First Procedure Using Evolut™ FX+ TAVR System
The team of cardiovascular specialists from Washington Regional’s Walker Heart Institute recently treated the first patient using the Evolut™ FX+ transcatheter aortic valve replacement (TAVR) system. The system offers a minimally invasive alternative to open-heart surgical aortic valve replacement for patients with severe aortic stenosis. Washington Regional first began performing TAVR procedures in 2018 and is the first hospital in Arkansas to provide this new approach to the TAVR procedure.
Aortic stenosis occurs when the leaflets, or flaps, of the aortic valve become stiff and have difficulty opening and closing, making the heart work harder to pump blood to the rest of the body. Symptoms include fatigue or weakness, dizziness, shortness of breath, chest pain or pressure, heart palpitations, fainting and cough. The condition can limit a person’s ability to participate in daily activities. If left untreated, 50% of patients with severe aortic stenosis can die from heart failure in as little as two years.
During the TAVR procedure, a replacement heart valve is implanted by maneuvering a thin, flexible tube, or catheter, with the replacement valve through a blood vessel. The physician views images of the patient’s heart to guide the catheter to the diseased valve, where the replacement valve is then deployed. The new valve starts working immediately to help blood flow more efficiently through the heart.
"It is encouraging to see how the Evolut FX TAVR platform has evolved considerably over time and brought our heart teams another treatment option," said Dr. Zubair Ahmed, an interventional cardiologist with Washington Regional Cardiovascular Clinic, part of the Walker Heart Institute. “This newest iteration of the Evolut TAVR system offers a modified diamond-shaped frame design that provides more space for catheter maneuverability and allows physicians to better access patients' coronary arteries, which is especially beneficial for younger patients who may need additional procedures in the future.”
“Washington Regional’s Walker Heart Institute is the region’s leader in TAVR procedures,” said Washington Regional Chief Operating Officer Birch Wright. “Offering our patients this newest iteration of an established and trusted platform is one more way we are fulfilling Washington Regional’s mission of improving the health of people in the communities we serve.”
If you or someone you know have symptoms of severe aortic stenosis, talk to your doctor to see if TAVR is a possible treatment option.